JPRN-UMIN000036569
Not yet recruiting
未知
An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01 for nasal tube feeding patients - An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01
Michinoo hospital0 sites20 target enrollmentApril 22, 2019
Conditionsnasal tube feeding patients
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- nasal tube feeding patients
- Sponsor
- Michinoo hospital
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Subjects who have serious disease such as liver, kidney, heart, lung, digestive, hematological and metabolic. 2\. Subjects who have history of drug or serious food allergy. 3\. Subjects who are participate in the other study about drug during the study period. 4\. Subjects whose energy doses are not stable for the last 1 month. 5\. Subjects judged inappropriate for the study by the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An exploratory study to evaluate the efficacy of the single ingestion of milk protein hydrolysate on cerebral activity.JPRN-UMIN000025347Morinaga Milk Industry Co., LTD.36
Active, not recruiting
Phase 1
The exploratory study of EFE in COVID-19 patientsCOVID-19JPRN-jRCT2031210063Odaguchi Hiroshi156
Recruiting
Not Applicable
Exploratory study to explore the effectiveness of "MyEverycise" in improving exercise persistence to prevent dementia and frailtyJPRN-UMIN000050943ational Center for Geriatrics and Gerontology30
Completed
Not Applicable
A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofujipapuloerythroderma of OfujiJPRN-UMIN000031161Kobe University Graduate School of Medicine10
Active, not recruiting
Phase 1
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2016-001505-17-ESFAES FARMA, S.A.115